Rare Blood Clotting
-
{
- All
- News
- Videos
-
World Haemophilia Day 2026: Why Are Men More Likely To Develop Haemophilia?
On World Haemophilia Day 2026, Dr Rahul Bhargava explains why haemophilia affects men more than women. And understanding how the disorder can occur in your body, here is what you need to know about haemophilia.
-
Understanding Hemophilia: Doctor Explains Symptoms, Treatment And Daily Challenges
Hemophilia is a rare genetic bleeding disorder affecting clotting ability. Here are its symptoms, treatment options, and everyday challenges, highlighting how early diagnosis, modern therapies, and lifestyle care can improve quality of life.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Clotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford Study
The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday.
-
Blood Clot "Very Rare" Side Effect Of Johnson & Johnson Vaccine: EU Drug Regulator
Europe's medicines regulator said Tuesday that blood clots should be listed as a "very rare" side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweighed the risks.
-
Canadian PM Justin Trudeau Gets First Dose Of AstraZeneca Covid Vaccine
Prime Minister Justin Trudeau received a first dose of the AstraZeneca Covid vaccine on Friday, seeking to reassure Canadians it is safe despite very rare but serious blood clots in a handful of cases among millions vaccinated.
-
Johnson & Johnson Vaccine's Benefits Outweigh Rare Blood Clots Risk: EU Agency
Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
-
World Haemophilia Day 2026: Why Are Men More Likely To Develop Haemophilia?
On World Haemophilia Day 2026, Dr Rahul Bhargava explains why haemophilia affects men more than women. And understanding how the disorder can occur in your body, here is what you need to know about haemophilia.
-
Understanding Hemophilia: Doctor Explains Symptoms, Treatment And Daily Challenges
Hemophilia is a rare genetic bleeding disorder affecting clotting ability. Here are its symptoms, treatment options, and everyday challenges, highlighting how early diagnosis, modern therapies, and lifestyle care can improve quality of life.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Clotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford Study
The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday.
-
Blood Clot "Very Rare" Side Effect Of Johnson & Johnson Vaccine: EU Drug Regulator
Europe's medicines regulator said Tuesday that blood clots should be listed as a "very rare" side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweighed the risks.
-
Canadian PM Justin Trudeau Gets First Dose Of AstraZeneca Covid Vaccine
Prime Minister Justin Trudeau received a first dose of the AstraZeneca Covid vaccine on Friday, seeking to reassure Canadians it is safe despite very rare but serious blood clots in a handful of cases among millions vaccinated.
-
Johnson & Johnson Vaccine's Benefits Outweigh Rare Blood Clots Risk: EU Agency
Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
